Jump to main content
博士論文

The combination of HLA-B[*]15:01 and DRB1[*]15:01 is associated with gemcitabine plus erlotinib induced-interstitial lung disease in patients with advanced pancreatic cancer

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

The combination of HLA-B[*]15:01 and DRB1[*]15:01 is associated with gemcitabine plus erlotinib induced-interstitial lung disease in patients with advanced pancreatic cancer

Persistent ID (NDL)
info:ndljp/pid/10312014
Material type
博士論文
Author
西村, 明子
Publisher
西村, 明子
Publication date
2016
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
神戸大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
西村, 明子
Publication, Distribution, etc.
Publication Date
2016
Publication Date (W3CDTF)
2016
Alternative Title
進行膵癌患者におけるゲムシタビンとエルロチニブによる間質性肺疾患に対するHLA-B[*]15:01とDRB1[*]15:01の組み合わせの関連
Degree grantor/type
神戸大学
Date Granted
2016-03-25
Date Granted (W3CDTF)
2016-03-25